Welcome to 360 Compliance
    360

    UK released a guidance for using the new UK product making brought by British Exit (Brexit) from the EU

    The Department for Business of the UK, Energy & Industrial Strategy released guidance for using the new UK product making called UKCA on February 2, 2019. In most cases CE marking will still be available for products being placed on the UK market, however, if products require third-party assessment of conformity, and if this has been carried out by a UK conformity assessment body, the new UKCA marking will have to be applied after March 29, 2019 (where required by legislation). This will not be the case if the certificate of conformity has been transferred to an EU-recognized body (in which case the CE marking would apply).” Additional guidance about UKCA marking will be announced by the authority shortly.

    For more information see

    360Compliance provides Testing & Certification for type approval services and global market access in 195 countries. With proven expertise in worldwide regulations, 360Compliance can help your company shorten time to any market, minimize risks and manage the regulatory process from A-Z.

    Share this:

    You may also be interested

    Manufacturers-must-comply-with-FCC-regulations-for-safe-and-quality-RF-devices
    Conform with FCC regulations, or face consequences
    January 25, 2024
    Importance of FCC Regulations for RF Devices As manufacturers, we know how crucial it is to follow the FCC regulations for radio frequency (RF) devices. These rules protect the electromagnetic spectrum from harmful interference and ensure the quality and safety of our products. If we ignore or violate these rules, we could face serious consequences, such as hefty fines or legal actions. A recent example is a Brooklyn-based company facing a proposed fine of more than $1.2 million for marketing 33 device models without getting the required equipment authorization from the Federal Communications Commission. Understanding FCC Regulations in Title 47 Part 15 The FCC spells out its regulations in Title 47 Part 15 of the Code of Federal Regulations(CFR). This covers electromagnetic compatibility (EMC) for RF-emitting devices. These regulations establish strict requirements and emission limits for various devices, depending on their purpose and potential spectrum impact. To comply with these regulations, we need to evaluate our equipment through testing and measurement procedures that verify its adherence to the specified standards.  The marketing rules for licensed transmitters are in in Part 2, Subpart I, Section 2.803. In accordance with FCC Part §2.803, “ Marketing of radio frequency devices prior to equipment authorization” isn't allowed. Therefore, before selling equipment in the US, we need to ensure it complies with FCC regulations.  The company in question failed to do this evaluation and got caught by the FCC. See the FCC notice at the links below.  FCC-23-113A1.docx FCC-23-113A1.pdf FCC-23-113A1.txt Get Certified with 360Compliance In summary, complying with FCC requirements is not only a legal duty but also a key factor in ensuring the quality and safety of our products and the integrity of the electromagnetic spectrum. We should always be aware of these regulations and use the best tools and practices to meet them. If you don’t want a 1.2M$ fine, get your products certified for global markets with 360Compliance! Avoid costly mistakes and ensure your products meet global standards like FCC, CE, EMC, and Wireless across 195 countries. Partner with 360Compliance for comprehensive turn-key testing and certification services, giving you peace of mind and a competitive edge in the global market.
    FDA-recognized-AIM-7351731-Medical-Electrical-Equipment
    FDA AIM 7351731 – Immunity for Wireless device
    January 16, 2024
    If you are a medical device manufacturer, you may be aware of the importance of ensuring that your products are immune to radio frequency (RF) interference from radio frequency identification (RFID) readers and other sources. RF interference can cause malfunction, degradation, or damage to medical devices, which can compromise patient safety and quality of care. The Food and Drug Administration(FDA) requires medical device manufacturers to demonstrate immunity to RF interference as part of the premarket approval process. One of the standards that the FDA references for this purpose is AIM 7351731, which covers the testing of medical electrical equipment and systems against RFID readers. This FDA-recognized standard addresses a range of common RFID technologies used in healthcare settings, such as passive and active tags, low-frequency (LF), high-frequency (HF), and ultra-high-frequency (UHF) systems. However, AIM 7351731 testing scope does not address other RF sources that may be present in the same environment as medical devices, such as Wi-Fi, ultra-wideband (UWB), 5G cellular, wireless power transfer (WPT), near-field communication (NFC), metal detectors, electronic article surveillance (EAS), electrosurgical cut/coagulate, diathermy, and X-ray. These sources can also generate RF interference that can affect medical devices. To address this gap, the FDA has recently issued a new guidance document that expands the scope of RF immunity testing beyond RFID readers to include other RF emitters. The document recommends how to select the appropriate RF emitters for testing based on the intended use environment of the medical device. For example, devices used in home, doctor's office, or sleep lab settings may not require testing against all RF emitters. On the other hand, devices used in diverse settings like operating rooms or emergency departments may require more rigorous testing. For implanted devices, the FDA recommends testing against all RF emitters, regardless of the use environment, because of the potential exposure scenarios.  An implanted device may encounter a metal detector at an airport security checkpoint, or a WPT device at a charging station. Therefore, it is essential to ensure that implanted devices are immune to all possible RF interference sources. As a medical device manufacturer, you should follow the FDA guidance document and the AIM 7351731 standard to ensure that your products are immune to RF interference from RFID readers and other RF emitters. This will help you comply with the regulatory requirements and ensure the safety and performance of your devices in various use environments. Are you looking for guidance on how to comply with the latest regulations in your industry? Do you need assistance with the documentation and certification process? If so, you can rely on 360Compliance experts to help you out! We have the experience and expertise to provide you with the best solutions for your compliance needs. We offer comprehensive consulting, training, and certification services tailored to meet AIM 7351731 compliance testing standards. Our expert team is dedicated to guiding you through the intricacies of FDA approval, ensuring that your medical devices not only meet the latest EMC requirements but also adhere to the specific criteria outlined in AIM 735173. Contact us today and let us know how we can help you achieve your compliance goals! Other Sources of electromagnetic (EMC) Immunity Immunity to specific RF emitters that are known sources of electromagnetic disturbances: Metal detectors Electronic Article Surveillance system (EAS) WPT (Wireless Power Transfer) 5G Cellular emitters (in both FR1 and FR2 using equipment to generate the frequencies, modulations, and power of 5G cellular including mmWave technology) Electrosurgical devices Electrocautery devices Diathermy NFC systems X-ray This requirement is per FDA Guidance Document - Electromagnetic Compatibility (EMC) of Medical Devices June 6, 2022  
    ANATEL-Certification
    ANATEL's Insights from Official Letter 429/2023
    January 10, 2024
    The Brazilian National Telecommunications Agency (ANATEL) has recently issued an official letter that clarifies some aspects of its regulatory framework for telecommunications services. The letter, dated December 15, 2023, addresses some questions raised by the industry and the public regarding the interpretation and application of ANATEL's regulations. The main topics covered by the letter are: - The distinction between telecommunication services and value-added services, and the implications for licensing, taxation and consumer protection. - The criteria for determining the dominant position of a telecommunication service provider in a relevant market, and the obligations and restrictions imposed on such providers to prevent abuse of market power. - The rules for interconnection and access to essential facilities, such as poles, ducts and towers, and the mechanisms for resolving disputes and ensuring fair compensation. - The principles and procedures for spectrum management, allocation and assignment, and the conditions for sharing and trading spectrum rights. - The guidelines for promoting competition, innovation and investment in the telecommunication sector, and the role of ANATEL as a regulator and facilitator. The letter is a valuable source of information for anyone interested in understanding the current state and future direction of ANATEL's regulatory evolution. It also reflects ANATEL's commitment to transparency, dialogue and cooperation with all stakeholders in the telecommunication industry. At 360Compliance, our team of experts specializes in providing professional guidance to businesses navigating the intricate ANATEL certification process. With a deep understanding of the regulatory landscape, we meticulously ensure that your products meet the necessary standards, facilitating a seamless and professional certification journey.    

    Get in touch to take the next step with 360Compliance

    Contact us